Login
Pacific Biosciences of California Inc logo

Pacific Biosciences of California Inc

pacb.com

Pacific Biosciences of California Inc (NASDAQ: PACB) is a life sciences instrumentation company that develops and commercializes DNA sequencing systems based on its Single Molecule, Real-Time (SMRT) sequencing technology. Revenue comes from instrument sales, consumables sold on a per-run basis, and service contracts tied to its installed base of sequencing systems. The filing excerpts provided do not contain sufficient detail to characterize market position, segment revenue percentages, customer counts, named competitors, geographic mix, or capital structure with the specificity required for grounded disclosure. Accordingly, those elements are omitted from this description pending review of complete filing content.

Products & Services

SMRT sequencing instruments and related consumable reagents and service contracts. Specific product names and SKUs are not supported by the provided excerpts.

Revenue Model

Instrument sales, consumable reagents consumed on a per-run basis, and service/support contracts. The filing excerpts provided do not include revenue breakdowns by stream or fiscal period.

Customers & Markets

The provided filing excerpts do not specify customer types, end markets, or customer concentration metrics.

Geographic Exposure

The provided filing excerpts do not specify geographic revenue mix or operating footprint.

Financial Snapshot

Revenue
TTM
$160.0M
Gross Margin
TTM
37.49%
Net Income
TTM
-$128.6M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
565.4%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$2.366M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$116.2M

Stock Price

Loading...
Market Cap: $484.54 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support